Cargando…
US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681452/ https://www.ncbi.nlm.nih.gov/pubmed/37641498 http://dx.doi.org/10.1002/psp4.13033 |
| _version_ | 1785142535306346496 |
|---|---|
| author | Shord, Stacy S. Zhu, Hao Liu, Jiang Rahman, Atiqur Booth, Brian Zineh, Issam |
| author_facet | Shord, Stacy S. Zhu, Hao Liu, Jiang Rahman, Atiqur Booth, Brian Zineh, Issam |
| author_sort | Shord, Stacy S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10681452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106814522023-08-28 US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer Shord, Stacy S. Zhu, Hao Liu, Jiang Rahman, Atiqur Booth, Brian Zineh, Issam CPT Pharmacometrics Syst Pharmacol Perspectives John Wiley and Sons Inc. 2023-08-28 /pmc/articles/PMC10681452/ /pubmed/37641498 http://dx.doi.org/10.1002/psp4.13033 Text en Published 2023. This article is a U.S. Government work and is in the public domain in the USA. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Perspectives Shord, Stacy S. Zhu, Hao Liu, Jiang Rahman, Atiqur Booth, Brian Zineh, Issam US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_full | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_fullStr | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_full_unstemmed | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_short | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_sort | us food and drug administration embraces using innovation to identify optimized dosages for patients with cancer |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681452/ https://www.ncbi.nlm.nih.gov/pubmed/37641498 http://dx.doi.org/10.1002/psp4.13033 |
| work_keys_str_mv | AT shordstacys usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT zhuhao usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT liujiang usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT rahmanatiqur usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT boothbrian usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT zinehissam usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer |